Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13D/A Stake Beneficial Ownership Report
  7. SC TO-I Deal Tender Offer Statement by Issuer
  8. SC TO-C Deal Written Communication Relating to an Issuer
  9. 8-K Event Other events
  10. 424B3 Offering Prospectus
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. 8-K Event Executive or director change
  14. UPLOAD Other SEC-generated Letter
  15. S-3 Offering Registration Statement
  16. 8-K Event Executive or director change
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. D Other Notice of Sales of Unregistered Securities
  20. SC 13D Stake Beneficial Ownership Report

Page 8 of 18 · 348 filings